Skip to content
Top Globe News – Lifestyle
Author:
NeuroOne Medical Technologies Corporation
NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order
October 5, 2026
NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement
September 17, 2026